New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 6, 2014
12:01 EDTAEZSAeterna Zentaris NDA filing for macimorelin acetate accepted by FDA
Aeterna Zentaris announced that the Food and Drug Administration has accepted for filing the company's New Drug Application for its ghrelin agonist, macimorelin acetate, in Adult Growth Hormone Deficiency. The company's NDA, submitted on November 5, 2013, seeks approval for the commercialization of macimorelin acetate as the first orally-administered product that induces growth hormone release to evaluate AGHD. The acceptance for filing of the NDA indicates the FDA has determined that the application is sufficiently complete to permit a substantive review, the company said.
News For AEZS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 5, 2015
18:21 EDTAEZSOn The Fly: After Hours Movers
UP AFTER EARNINGS: YY Inc. (YY), up 5.2%... Finisar (FNSR), up 5%... Martha Stewart Living (MSO), up 5.1%... Thor (THO), up 3.5%... The Fresh Market (TFM), up 2.5%... Cooper (COO), up 2.6%. ALSO HIGHER: Calithera Biosciences (CALA), up 39% after gaining license to TransTech hexokinase inhibitors... Bank of America (BAC), up 2% following results of 2015 Dodd-Frank Stress Test. DOWN AFTER EARNINGS: Checkpoint Systems (CKP), down 20.4%... Emergent BioSolutions (EBS), down 8.5%. ALSO LOWER: Gap (GPS), down 2.1% after reporting February sales... AEterna Zentaris (AEZS), down 13.7% after filing to sell common units, no amount given... Citigroup (C), down marginally following results of 2015 Dodd-Frank Stress Test.
16:12 EDTAEZSAeterna Zentaris files to sell common units, no amount given
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use